(Q38102458)

28 August 2017

title

Oral tacrolimus as maintenance therapy for refractory ulcerative colitis--an analysis of outcomes in two London tertiary centres (English)

1 reference

28 August 2017

7

Ailsa L Hart

1 reference

28 August 2017

Jonathan Landy

1

1 reference

28 August 2017

Mahmood Wahed

2

1 reference

28 August 2017

Simon T C Peake

3

1 reference

28 August 2017

Mohammed Hussein

4

1 reference

28 August 2017

Siew C Ng

5

1 reference

28 August 2017

James O Lindsay

6

1 reference

28 August 2017

publication date

25 April 2013

1 reference

Journal of Crohn's and Colitis

28 August 2017

published in

1 reference

28 August 2017

volume

7

1 reference

28 August 2017

issue

11

1 reference

28 August 2017

page(s)

e516-21

1 reference

Clinical course of ulcerative colitis.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

The efficacy of methotrexate for maintaining remission in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

ABCB1 Single-Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.03.008

10.1016/J.CROHNS.2013.03.008

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference